Announcing BIOVIA Discovery Studio 2017 R2 Built on BIOVIA Pipeline Pilot 2017 R2, BIOVIA Discovery Studio 2017 R2 stands as BIOVIA’s major release for predictive sciences and modeling and simulation in the life sciences. Small Molecules affinity modeling Rank ligand binding using In situ MM-GBSA scoring Accurately predict relative ligand binding energy using free energy perturbation (FEP) Rational Antibody design Model full-length bispecific antibody structures Graft Fab models onto full-length templates Antibody cascade modeling workflow now supports grafting full length structures Enhanced De Novo Loop prediction Forcefield CHARMM 41b1 support Full support of CHARMM patching mechanism Custom improper definition support General Generate export files for 3D Printing of molecular models Enhanced antibody workflow components for protocol authoring